USA Ramona Sequeira of Takeda has taken the reins as chair of US industry lobby group PhRMA’s Board of Directors, becoming the first ever woman to hold the role. She succeeds Lilly Chairman and CEO David Ricks at a juncture when the industry is under pressure from proposed US pricing reforms…
MEA Seasoned executive Mohamed Nasser currently oversees 16 markets for Amgen across the MEA region, including its most important – Saudi Arabia. He shares some of the key skills that pharma executives overseeing his region need to succeed. As region head for a company that is only 40 years old,…
Saudi Arabia Before Crown Prince Mohammed bin Salman assumed office in 2017, Saudi Arabian women had only a marginal presence in the Kingdom’s labour force. However, since then notable milestones achieved include granting women the right to drive, access to sports, a first female ambassador, freedom to travel, the right to live…
Denmark Although Zealand Pharma has been around for 23 years, it has made rapid progress since French national Emmanuel Dulac took the helm as president and CEO in April 2019, with a first new drug application (NDA) and approval, a first in-licensing, and two acquisitions. Dulac – a veteran of…
Turkey Few Turkish companies are experiencing such a transformational moment as GEN. In 2021 alone, the Ankara-based organization made its public debut on the Istanbul Stock Exchange and signed an exclusive collaboration agreement with Dutch biotech Sulfateq BV for the development and commercialization of a therapy against Alzheimer’s and other neurodegenerative…
China Portuguese national Isabel Afonso, a Novartis and Sandoz veteran of almost 20 years, has taken on a new role as general manager of Novartis’ highly strategic oncology franchise in China as of November 2021. Since first joining the company back in 2002, Afonso held a variety of roles IT…
Saudi Arabia Dr Mona Obaid, chief medical officer for Lilly in Saudi Arabia, explains how the country’s Vision 2030 is shaping the pharma industry and society at large, Lilly’s role in increasing awareness of diabetes, and the opportunities for Saudi in regional clinical trials. There is a huge opportunity ahead for…
Saudi Arabia In a recent royal decree, Saudi Arabia has appointed Fahad Al-Jalajel as its Minister of Health, replacing Dr Tawfiz Al-Rabia who had served since 2016. Here, we give a quick run-through of Al-Jalajel’s career thus far. The holder of a bachelor’s degree in computer science from King Saud University,…
APAC Francis Van Parys, vice president commercial Asia-Pacific at Cytiva, a global life sciences leader dedicated to advancing and accelerating therapeutics, highlights the firm’s tireless work to meet the exponential demand for the research, development, and manufacturing of therapies and vaccines against COVID-19. Van Parys also outlines the opportunities and challenges…
APAC The Asia-Pacific (APAC) region is home to around 1.44 billion people, over 60 percent of the world’s population, and a vast diversity of cultures, infrastructures, and economic development. Managing a life sciences company across multiple countries in this region can be extremely challenging but hugely important on both a human…
Turkey Drawing on over a dozen interviews with C-level pharmaceutical industry executives in Turkey, PharmaBoardroom has compiled a strategic overview of Turkey’s pharma talent potential, including what local talent can offer to global organisations, why the well-educated and cost-efficient domestic labour force is so important to the Turkish pharma market’s future,…
See our Cookie Privacy Policy Here